Navigation Links
Emisphere Technologies, Inc. Announces 2008 First Quarter Financial Results
Date:5/7/2008

1,493 3,524

Interest expense, net (572) (624)

Total other income 2,520 3,214

Net loss $(3,942) $(3,888)

Net loss per share, basic $(0.13) $(0.14)

Net loss per share, diluted $(0.13) $(0.26)

Weighted average shares

outstanding, basic 30,336,928 28,311,744

Weighted average shares

outstanding, diluted 30,336,928 28,618,574

EMISPHERE TECHNOLOGIES, INC.

CONDENSED BALANCE SHEETS

March 31, 2008 and December 31, 2007

(in thousands, except share and per share data)

March 31, December 31,

2008 2007

(unaudited)

Assets:

Current assets:

Cash, cash equivalents, and investments $9,858 $13,854

Accounts receivable 127 240

Prepaid expenses and other current assets 828 1,035

Total current assets 10,813 15,129

Equipment and leasehold improvements, net 1,946 2,074

Purchased technology, net 1,495 1,555

Restricted cash 246 246

Other assets 465 477

Total assets $14,965 $19,481

Liabilities and Stockholders' Deficit:

Current liabilities $3,832 $5,507

Notes payable
'/>"/>

SOURCE Emisphere Technologies, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Emisphere Technologies, Inc. Announces Conference Call for First Quarter 2008 Financial Results
2. Emisphere Reports Receipt of Notification from NASDAQ Regarding Non-Compliance with Continued Listing Requirements
3. Emisphere Technologies To Hold Annual Stockholders Meeting on May 8, 2008
4. Emisphere Technologies, Inc. Announces 2007 Fourth Quarter and Year End Financial Results
5. Emisphere Technologies, Inc. Announces Conference Call for 2007 Fourth Quarter and Year End Financial Results
6. Emisphere Technologies to Web Cast BIO CEO & Investor Conference Presentation February 12
7. Emisphere Technologies to Present at BIO CEO & Investor Conference on February 12
8. Emisphere to Host Business Strategy Conference Call on February 7
9. Emisphere Technologies, Inc. Moves Into New Corporate Headquarters
10. Emisphere Technologies, Inc. Appoints Gary Riley as Vice President Nonclinical Development & Applied Biology
11. Emisphere Technologies, Inc. and Eli Lilly and Company Settle Ongoing Litigation

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...swire/--BlueMarbleEnergyCorp.announcedtodaythatthe...)wererecentlyawarded$2millionbyWashingtonState,sCo.../publicpartnershiptoconstructthestate,sfirstspecia... "Thisinvestmentwillsignificantlyspeedthedevelopme...County,"saidBlueMarbleEnergyCEOKellyOgilvie."Weare...
(Date:11/24/2009).../PRNewswire-FirstCall/--ArenaPharmaceuticals,Inc.(...duledtopresentatthePiperJaffray21stAnnualHealthCar...8:30a.m.PacificTime)attheNewYorkPalaceHotelinNewYo...eOfficer,isscheduledtoprovideanoverviewofthecompan...ams. ,, Aliveaudiowebcastofthepresentationwillb...
(Date:11/24/2009)...swire-FirstCall/--CellTherapeutics,Inc.(CTI)(Nasda...iperJaffrayHealthCareConference.Theconferencewillb..., CTIwillpresentonTuesday,December1at11:00a.m.Eas...,spresentationwillbeavailableat www.celltherapeuti...s. , ,PiperJaffrayHealthCareConference,NewYorkPal...
(Date:11/23/2009)...Nov.23/PRNewswire-FirstCall/--PDLBioPharma,Inc.(PD...ishedNovember27,2009astheex-dividenddateforits$200...hesecuritizationtransactioncompletedonNovember2,20...kholdersofrecordontherecorddate,December1,2009.NAS...at$1.67pershareofcommonstockforpurposesoftheex-div...
Breaking Biology Technology:Blue Marble Energy, OPDA Awarded $2M by WA's Community Economic Revitalization Board 2Arena Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 2PDL BioPharma Announces Ex-Dividend Date of November 27 for Special Dividend 2
...hances NeoStem,s Presence in Anti-Aging Arena , ,...US: NBS), which is pioneering the pre-disease coll...stem cells for future medical need, announced toda...exclusive worldwide rights to innovative stem cell...nd body procedures and skin rejuvenation. , , The...
...D, Pa., Feb. 23 Endo Pharmaceuticals (Nasdaq: E... the tender offer by its wholly owned subsidiary, ...res of common stock of Indevus Pharmaceuticals, In...; Trust Company, the depositary for the tender off...rk City time, on February 20, 2009, the initial ex...
..., Calif., Feb. 23 CUREXO Technology Corporation, ...age-directed robotic products for orthopaedic appl...C(R) Surgical System, announced today that they wi...ion of Orthopaedic Surgeons Annual Conference at t...hrough the 27th, Booth #3456. , , For the first t...
Other Biology Technology:NeoStem Obtains Exclusive Worldwide License to Innovative Stem Cell Technology and Applications for Anti-Aging Skin Rejuvenation Therapies 2NeoStem Obtains Exclusive Worldwide License to Innovative Stem Cell Technology and Applications for Anti-Aging Skin Rejuvenation Therapies 3Endo Pharmaceuticals Successfully Completes Tender Offer for Shares of Indevus Pharmaceuticals and Announces Subsequent Offering Period 2Endo Pharmaceuticals Successfully Completes Tender Offer for Shares of Indevus Pharmaceuticals and Announces Subsequent Offering Period 3CUREXO Technology Corporation Launches Its ROBODOC(R) Surgical System at Upcoming Orthopaedic Conference in Las Vegas 2
(Date:11/24/2009)...able in Spanish . , The presence of increas...matory substances in the blood, hinders the loss a...rch project of the University of Navarra conducted...chool of Pharmacy. , The project, entitled "A nu...he control of body weight and inflammation," exami...
(Date:11/23/2009)...community-associated strain of the deadly superbug...st common antibioticsposes a far greater health th...nto hospitals, according to a study in the Decembe...e new threat is easily picked up in fitness center...sed the overall burden of MRSA within hospitals, t...
(Date:11/23/2009)..., 2009 - The time of day matters to forest trees d...uced by a research team led by Professor Malcolm C...principal for research and colleagues in the depar...e campus. , Capitalizing on their previous wor...earch team examined how poplar trees use their 45,...
Breaking Biology News(10 mins):It can be predicted the reaction obese patients will have to a diet 2New study finds MRSA on the rise in hospital outpatients 2Time of day matters to thirsty trees, U of T researcher discovers 2Significantly Higher Percentage of Hetastarch Recipients Underwent a Surgical Procedure Than Those Receiving Albumin Plasma Protein Fraction 57488 1Significantly Higher Percentage of Hetastarch Recipients Underwent a Surgical Procedure Than Those Receiving Albumin Plasma Protein Fraction 57488 2Significantly Higher Percentage of Hetastarch Recipients Underwent a Surgical Procedure Than Those Receiving Albumin Plasma Protein Fraction 57488 3TBGH Report on Status of Diabetes in Texas Indicates Growing Severity of Problem and Higher Cost of Care Than National Average 57487 1TBGH Report on Status of Diabetes in Texas Indicates Growing Severity of Problem and Higher Cost of Care Than National Average 57487 2TBGH Report on Status of Diabetes in Texas Indicates Growing Severity of Problem and Higher Cost of Care Than National Average 57487 3TBGH Report on Status of Diabetes in Texas Indicates Growing Severity of Problem and Higher Cost of Care Than National Average 57487 4Cohen Launches Second Statewide Tour 57485 1Cohen Launches Second Statewide Tour 57485 2
...stralian researchers have discovered a new gene th...ate cancer, as well as diabetes. , The gene, calle...ustralian Institute for Medical Research,s (WAIMR)...Peter Leedman, in collaboration with Professor Ber... Texas. , "When we baited our hook and went fishi...
...the transport of proteins within cells may underli...such as Huntington,s, ALS and Kennedy disease. Und...hese diseases may offer targets for future therapy...re Neuroscience, researchers from the University o...ow a chemical pathway that is obstructed in Kenned...
...f UniQuest,s 2006 Trailblazer innovation competiti... for motoneuronal diseases based on modifying boto...onal diseases cause a degeneration of the nerve pa...re severe and physically debilitating disorders wh...cles. Many of the diseases are incurable. , Dr Me...
Other Biology News:Gene discovery opens door to tackling disease 2Mechanism for neurodenegerative diseases linked to transport proteins 2
...orm 96 assays on one plate. The new ArraySlide 96 ...mm) individual printing surfaces for multiple simu...alysis studies. Unlike other systems, this device ... presence of contaminating adhesives. The chamber ...
...orm 96 assays on four slides. The new ArraySlide 2...mm x 7mm) individual printing surfaces for multipl...ing analysis studies. Unlike other systems, this d...ng the presence of contaminating adhesives. The ch...
...integrins in vascular proliferation, adhesion, and...rin family of cell adhesion receptors consists of ...osed of an a and b subunit that associate in a non...ersity of the integrin family are based upon the p...
Bio-Plex Manager Version 3.0 to 4.0 Workstation Software Upgrade Kit from Bio-Rad
Biology Products: